We undertake no obligation to revise our forward-looking statements to
reflect events or circumstances after the date hereof as a result of new
information, future events or otherwise.

scams nose

(Nasdaq: SNCI), a leading producer of advanced digital hearing aids, today
announced the release of its Innova product family. Net loss
was $3,477,000, or $.
North American sales of $9,594,000 in the first quarter 2005 were in line
with first quarter 2004 sales of $9,605,000, but first quarter 2005 included
sales from Tympany, which was acquired in December 2004.

audiology assistive

In addition,
Innova provides a complete line of hearing aid models from completely-in-the-
canal (CIC) to an innovative behind-the-ear (BTE) product.

pathology closely

Raguskus further stated, "Innova delivers unique technology solutions
for even the most challenging listening environments . I expect Innova
to drive an improvement in sales, gross margin and earnings in the future. European sales of
$12,278,000 in the first quarter 2005 were down 2% from first quarter 2004
sales of $12,584,000.0 million, and debt of $7.

The company will host a teleconference call in connection with this
release on Thursday, April 28, 2005 at 3:00 p.

easier hearing

With the development of
Innova, Sonic Innovations has continued its focus on delivering features that
translate into real-world benefit for the hearing impaired. Company Launches Next Generation Innova Product Family

SALT LAKE CITY, Sonic Innovations, Inc.5% in the first quarter 2005 was down from last year's first quarter level
of 55.

nose sensible

Actual
results may differ materially and adversely from those described herein
depending on a number of factors including, but not limited to, the following
risks: we face aggressive competition in our business; acquisitions could be
difficult to integrate, disrupt our business and harm our operating results;
we may lose a large customer or suffer a reduction in orders from a large
customer; we must have innovative, technologically superior products to
compete effectively; our products, due to their complexity, may contain errors
or defects that are only discovered after sales by our customers, thus harming
our reputation and business; we may have issues with intellectual property; we
may harm our relationships with our traditional customers by selling in
non-traditional ways, such as to high volume general retail or electronics
retail stores, or through ear-nose-throat physicians, or by having the primary
care physician make referrals of Otogram-tested hearing impaired patients
through our Hearing Health Network; and we have important international
operations, particularly in Germany and Australia, which expose us to a
variety of risks that could result in lower sales .16) $.

tronics nose

Sonic Innovations designs, develops, manufactures and markets advanced
digital hearing aids designed to provide the highest levels of satisfaction
for hearing impaired consumers , and proprietary auditory testing equipment
that automates the four most commonly performed hearing tests. For additional information
regarding the risks inherent in our business, please see "Factors That May
Affect Future Performance" included in our Annual Report on Form 10-K for the
year ended December 31, 2004, as filed with the Securities and Exchange
Commission.

intech hearing

The early reactions to Innova by our hearing care
professional customers and hearing impaired consumers have been very positive ,
and we very much expect Innova to fuel our sales growth beginning immediately.
We undertake no obligation to revise our forward-looking statements to
reflect events or circumstances after the date hereof as a result of new
information, future events or otherwise.S.
If you wish to hear a digital playback of the call, please call
(888) 286-8010 within the U.

nose jade

m.
Consolidated Statement of Operations Information
(In thousands, except per share data)
(Unaudited)

Quarter ended
March 31
2005 2004

Net sales $25,891 $26,306
Cost of sales 12,034 11,729

Gross profit 13,857 14,577

Selling, general and administrative expense 14,854 10,044
Research and development expense 2,352 2,554

Operating profit (loss) (3,349) 1,979

Other expense, net 40 49

Income (loss) before income tax provision (3,389) 1,930

Income tax provision 88 342

Net income (loss) $(3,477) $1,588

Basic earnings (loss) per common share $(.16) $.

audiologist throat

Sonic Innovations Inc. Introduces Premium Digital Hearing Aid Line

stethtron assistive

audiological pathology

07 per share, in the first quarter 2004. Gross margin of
53.

throat respiration

Innova launched last week at the
American Academy of Audiology Convention in Washington, D."
Capitalizing on what it believes to be an advanced understanding of human
hearing, Sonic Innovations designs, develops, manufactures and markets
advanced digital hearing aids intended to provide the highest levels of
satisfaction for hearing-impaired consumers.
(Nasdaq: SNCI), a leading producer of advanced digital hearing aids, today
announced results for the first quarter ended March 31, 2005. Operating
expenses in the first quarter 2005 of $17,206,000 increased 37% from operating
expenses of $12 ,598,000 in last year's first quarter principally as a result
of Tympany and significant training and marketing costs associated with the
introduction of the Company's next generation hearing aid product, Innova.

This press release contains "forward-looking statements" as defined under
securities laws, including statements concerning the Innova product family
fueling sales growth beginning immediately and the Tympany business gaining
traction and producing less dilution through the balance of 2005.

audiological tronics

"We have developed a new hearing aid product line that offers not only the
high-end features required today for a premium digital hearing aid, but also
advanced patent-pending features that are unavailable elsewhere in the
marketplace," stated Andy Raguskus, the Company's President and CEO. Innova's most exciting new feature, DIRECTIONALfocus(TM),
delivers an unprecedented directional measure of 11 dB through a revolutionary
new form of patent-pending adaptive directionality .

closely hearing

Mr. These and
other risk factors are described in "factors that may affect future
performance " included in our annual report on Form 10-K for the year ended
December 31, 2004, as filed with the Securities and Exchange Commission.
Eastern Time)., and ask to be connected to
the Sonic Innovations teleconference.S., and enter
confirmation code 39020754 (available through May 3, 2005), or access the
playback through our website.

Sonic Innovations, Inc.08

Diluted earnings (loss) per common share $(.

listening murmurs

Actual results may differ materially and adversely from those
described herein depending on a number of factors, including the competitive
performance and features of our products; demand for and market acceptance of
our products; delays in completing or introducing our new products; and the
announcement or introduction of new products by our competitors.

scams nidcd

m.
To participate in the conference call, please call toll free
(800) 561 -2731, or (617) 614-3528 outside the U.sonici.

stethoscope stethtron

Innova is the Company's
next generation of high-end digital hearing aid technology offering unmatched
hearing aid consumer benefits and features.
Gross profit of $13,857,000 in the first quarter 2005 was down 5% from
gross profit of $14,577 ,000 in last year's first quarter.

nose stethoscope

This press release contains "forward-looking statements " as defined under
securities laws, including statements concerning the performance of the Innova
product family and potential improvement in sales, gross margin and earnings
in the future.com .

closely aids

C.S.

listening throat

Innova(TM) Product Family Debuts at the
American Academy of Audiology Convention

SALT LAKE CITY, Sonic Innovations, Inc."
As of March 31, 2005, Sonic Innovations had cash and marketable
securities, including restricted and long-term marketable securities, of
$30. Mountain Time (5:00 p. A live webcast will also be available
through our website at http://www.

respiration closely

Net sales were
$25,891,000 in the first quarter 2005, down 2% from the Company 's all time
quarterly record net sales of $26,306,000 in the first quarter 2004.07

Weighted average number of common shares
outstanding:
Basic 21,215 20,408

Diluted 21,215 22,790

Sonic Innovations, Inc.
Consolidated Balance Sheet Information
(In thousands)
(Unaudited)
March 31, December 31,
2005 2004
Assets:

Cash and marketable securities $29,971 $32,349
Accounts receivable 15,586 16,092
Inventories 11,170 9,799
Property and equipment 9,779 10,086
Goodwill and intangibles 41,023 42,300
Other 5,348 4,660

Total assets $112,877 $115,286

Liabilities:

Accounts payable $9,311 $8,315
Accrued liabilities and other 20,683 17,444
Loan payable 7,748 8,525
Deferred revenue 8,543 9,899

Total liabilities 46,285 44,183

Shareholders' equity:

Common stock 22 22
Additional paid-in capital 118,211 118,135
Accumulated deficit (54,274) (50,797)
Other 2 ,633 3,743

Total shareholders' equity 66,592 71,103

Total liabilities and shareholders' equity $112,877 $115,286

audiology amplification

Continuing Sonic Innovations' legacy of outstanding Noise Reduction
algorithms, Innova features Adaptive Noise Reduction, which intelligently
varies the level of noise reduction applied in different listening
environments.

Sonic Innovations Announces Results for First Quarter 2005

Rest-of-world sales of $4,019,000 in the first quarter
2005 were also down 2% from first quarter 2004 sales of $4,117 ,000.4% as a result of lower-margin Tympany sales in 2005.7 million.

stethoscope audiologist

In addition, we expect the results from Tympany to be less dilutive through
the balance of 2005 as our diagnostics business gains traction . You may also visit our website for an
archive of prior press releases and earnings announcements ., or (617) 801-6888 outside the U.

audiology murmurs

Directionality is a
proven way to enhance speech understanding in background noise by emphasizing
sounds arriving in front of the hearing aid wearer (speech) and de-emphasizing
sounds that arrive to the side of and behind the wearer (noise).

16 per share, in the first quarter 2005 compared to net
income of $1,588,000, or $.
Andy Raguskus , President and CEO, stated, "I am pleased that we were able
to achieve our principal goal of launching our revolutionary Innova product
family in late March.